Bio-Rad Laboratories ROE 2006-2018 | BIO

Current and historical return on equity (ROE) values for Bio-Rad Laboratories (BIO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Bio-Rad Laboratories ROE for the three months ending December 31, 2018 was 3.92%.
Bio-Rad Laboratories ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-12-31 $0.36B $4.02B 8.00%
2018-09-30 $1.28B $4.90B 30.12%
2018-06-30 $1.03B $4.64B 27.64%
2018-03-31 $0.77B $4.49B 23.46%
2017-12-31 $0.12B $2.93B 4.32%
2017-09-30 $0.02B $2.85B 0.58%
2017-06-30 $0.01B $2.81B 0.44%
2017-03-31 $0.03B $2.71B 0.94%
2016-12-31 $0.03B $2.58B 0.96%
2016-09-30 $0.09B $2.70B 3.63%
2016-06-30 $0.09B $2.62B 3.69%
2016-03-31 $0.10B $2.54B 4.19%
2015-12-31 $0.11B $2.49B 4.60%
2015-09-30 $0.10B $2.43B 4.45%
2015-06-30 $0.10B $2.36B 4.35%
2015-03-31 $0.10B $2.20B 4.59%
2014-12-31 $0.09B $2.19B 4.07%
2014-09-30 $0.08B $2.18B 3.66%
2014-06-30 $0.06B $2.25B 2.82%
2014-03-31 $0.07B $2.23B 3.02%
2013-12-31 $0.08B $2.19B 3.71%
2013-09-30 $0.09B $2.12B 4.42%
2013-06-30 $0.14B $2.07B 7.00%
2013-03-31 $0.15B $2.03B 7.86%
2012-12-31 $0.17B $2.02B 8.64%
2012-09-30 $0.18B $1.94B 9.88%
2012-06-30 $0.19B $1.85B 10.38%
2012-03-31 $0.18B $1.84B 10.11%
2011-12-31 $0.18B $1.74B 10.57%
2011-09-30 $0.19B $1.69B 11.38%
2011-06-30 $0.19B $1.73B 11.79%
2011-03-31 $0.18B $1.61B 12.51%
2010-12-31 $0.19B $1.54B 13.35%
2010-09-30 $0.16B $1.43B 11.75%
2010-06-30 $0.15B $1.30B 11.74%
2010-03-31 $0.15B $1.30B 12.16%
2009-12-31 $0.15B $1.28B 12.36%
2009-09-30 $0.10B $1.23B 8.83%
2009-06-30 $0.09B $1.13B 8.17%
2009-03-31 $0.09B $1.06B 8.66%
2008-12-31 $0.09B $1.07B 8.24%
2008-09-30 $0.11B $1.05B 10.33%
2008-06-30 $0.11B $1.12B 10.60%
2008-03-31 $0.09B $1.08B 9.44%
2007-12-31 $0.09B $0.97B 10.12%
2007-09-30 $0.10B $0.95B 11.12%
2007-06-30 $0.09B $0.90B 11.06%
2007-03-31 $0.10B $0.86B 12.29%
2006-12-31 $0.10B $0.82B 13.45%
2006-09-30 $0.10B $0.79B 13.65%
2006-06-30 $0.09B $0.76B 13.30%
2006-03-31 $0.08B $0.70B 11.82%
2005-12-31 $0.08B $0.66B 12.50%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $9.156B $2.290B
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. The company is headquartered in Hercules, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $136.952B 27.07
Medtronic (MDT) Ireland $121.227B 17.72
Stryker (SYK) United States $72.547B 26.60
Boston Scientific (BSX) United States $51.696B 25.20
Baxter (BAX) United States $39.588B 25.32
Zimmer Biomet Holdings (ZBH) United States $25.898B 16.58
Smith & Nephew SNATS (SNN) United Kingdom $17.446B 0.00
Canopy Growth (CGC) Canada $14.852B 0.00
ResMed (RMD) United States $14.350B 27.21
Aurora Cannabis (ACB) Canada $9.141B 64.50
Hill-Rom Holdings (HRC) United States $6.962B 21.53
Perrigo (PRGO) Ireland $6.420B 10.41
Insulet (PODD) United States $5.800B 1956.80
GW Pharmaceuticals (GWPH) United Kingdom $5.092B 0.00
ICU Medical (ICUI) United States $4.698B 29.24
Haemonetics (HAE) United States $4.311B 38.24
Hutchison China MediTech (HCM) China $3.810B 0.00
Agios Pharmaceuticals (AGIO) United States $3.637B 0.00
Neogen (NEOG) United States $3.108B 47.74
NuVasive (NUVA) United States $2.892B 25.23
Quidel (QDEL) United States $2.514B 22.68
Aphria (APHA) $2.385B 105.89
National Vision Holdings (EYE) United States $2.274B 44.72
Cardiovascular Systems (CSII) United States $1.346B 966.50
HEXO (HEXO) $1.340B 0.00
Phibro Animal Health (PAHC) United States $1.283B 18.45
VAREX IMAGING (VREX) United States $1.275B 24.96
AtriCure (ATRC) United States $1.081B 0.00
MacroGenics (MGNX) United States $0.926B 0.00
Lantheus Holdings (LNTH) United States $0.911B 24.60
Cerus (CERS) United States $0.844B 0.00
PetIQ (PETQ) United States $0.831B 23.77
Omeros (OMER) United States $0.828B 0.00
NanoString Technologies (NSTG) United States $0.729B 0.00
Meridian Bioscience (VIVO) United States $0.715B 21.30
OraSure Technologies (OSUR) United States $0.664B 29.11
Eagle Pharmaceuticals (EGRX) United States $0.657B 22.35
Evolus (EOLS) United States $0.655B 0.00
TG Therapeutics (TGTX) United States $0.601B 0.00
LeMaitre Vascular (LMAT) United States $0.596B 28.35
Surmodics (SRDX) United States $0.563B 81.90
Quanterix (QTRX) United States $0.518B 0.00
BioLife Solutions (BLFS) United States $0.364B 150.23
Vapotherm (VAPO) United States $0.335B 0.00
Rockwell Medical (RMTI) United States $0.331B 0.00
Insys Therapeutics (INSY) United States $0.328B 0.00
Utah Medical Products (UTMD) United States $0.300B 19.49
Owens & Minor (OMI) United States $0.271B 3.76
Bovie Medical (APYX) United States $0.260B 0.00
Cytosorbents (CTSO) United States $0.241B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.238B 0.00
Zynex (ZYXI) United States $0.145B 15.52
Fonar (FONR) United States $0.137B 7.33
Surface Oncology (SURF) United States $0.116B 0.00
Chimerix (CMRX) United States $0.102B 0.00
Female Health (VERU) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
InfuSystems Holdings (INFU) United States $0.091B 0.00
United-Guardian (UG) United States $0.087B 19.84
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 17.14
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Senestech (SNES) United States $0.029B 0.00
Myomo (MYO) United States $0.022B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.29